Eye injection restores sight in patients with rare hypotony

A new eye injection has successfully restored sight in patients with previously untreatable hypotony, a rare condition causing progressive vision loss due to abnormally low eye pressure. Researchers at UCL and Moorfields Eye Hospital found that injections of hydroxypropyl methylcellulose (HPMC), a common gel used in eye surgery, increased eye volume and pressure, leading to vision improvement in seven of eight patients. This breakthrough offers hope for patients with hypotony, a condition that previously had limited treatment options and often resulted in blindness. Further studies are planned to optimize and expand access to this therapy.